![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0027.png)
27
treatment in acuteoptic neuritis. Neurology
2005;64:804-10.
20.
Mandler RN, Ahmed W, Dencoff JE. Devic’s
neuromyelitis optica: a prospective study of
seven patients treated with prednisone and
azathioprine. Neurology 1998;51:1219-20.
21.
Watanabe S, Misu T, Miyazawa I, Nakashima I,
Shiga Y, Fujihara K, et al. Low-dose
corticosteroids reduce relapses in neuromyelitis
optica: a retrospective analysis. Mult Scler
2007;13:968-74.
22.
Weinstock-Guttman B, Ramanathan M, Lincoff
N, Napoli SQ, Sharma J, Feichter J, et al. Study
of mitoxantrone for the treatment of recurrent
neuromyelitis optica (Devic disease). Arch
Neurol 2006;63:957-63.
23.
Bomprezzi R, Postevka E, Campagnolo D,
Vollmer TL. A review of cases of neuromyelitis
optica. Neurologist 2011;17:98-104.
24.
Cree BA, Lamb S, Morgan K, Chen A, Waubant
E, Genain C. An open label study of the effects
of
rituximab
in
neuromyelitis
optica.
Neurology. 2005;64:1270-2.
25.
Jacob A, Weinshenker BG, Violich I, McLinskey
N, Krupp L, Fox RJ, et al. Treatment of
neuromyelitis
optica
with
rituximab:
retrospective analysis of 25 patients. Arch
Neurol. 2008;65:1443-8.